Page 2 - Steven Slilaty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven slilaty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Slilaty Today - Breaking & Trending Today

Sunshine Biopharma Inc.: Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds

(1)
MONTREAL, QC / ACCESSWIRE / February 4, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has signed an exclusive license agreement with the University of Georgia ( UGA ) for two Anti-Coronavirus compounds which UGA had previously developed and patented. Sunshine Biopharma and UGA will advance the development of these two compounds in parallel with Sunshine Biopharma s own SBFM-PL4. The next step in the development plan involves testing of the efficacy of these compounds in transgenic mice. Mice which have been genetically engineered to become susceptible to infection by SARS-CoV-2, the causative agent of COVID-19, will be challenged with the virus and subsequently treated with the test compounds to determine if progression to diseases can be arrested. Such studies are anticipated to be underway later this month. ....

Kostenloser Wertpapierhandel , Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , University Of Georgia , Sunshine Biopharma , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , எடுப்போசை சுவாச , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் , மார்பக புற்றுநோய் , கருப்பை சர்கோமா , மகில் பல்கலைக்கழகம் ,

Sunshine Biopharma Inc.: Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033

(2)
MONTREAL, QC / ACCESSWIRE / February 2, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a new patent application covering Adva-27a, the Company s flagship anticancer compound. This newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Canada until 2033. The equivalent patent in the United States was issued in 2019 (US Patent Number 10,272,065) and similarly covers Adva-27a until 2033. The analogous patents are still pending in Europe. Sunshine Biopharma is the sole owner of all intellectual property rights pertaining to Adva-27a, including the first Adva-27a patent (US Patent Number 8,236,935) issued in 2012. ....

United States , Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , College Of Pharmacy , Canadian Intellectual Property Office , University Of Georgia , Sunshine Biopharma , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Acute Respiratory , Additional Information Contact , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , கல்லூரி ஆஃப் மருந்தகம் , கனடியன் அறிவுசார் ப்ராபர்டீ அலுவலகம் , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , கணையம் புற்றுநோய் ,

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United States , Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , Canadian Intellectual Property Office , College Of Pharmacy , University Of Georgia , Sunshine Biopharma , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Acute Respiratory , Additional Information Contact , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , கனடியன் அறிவுசார் ப்ராபர்டீ அலுவலகம் , கல்லூரி ஆஃப் மருந்தகம் , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , கணையம் புற்றுநோய் ,

Sunshine Biopharma Inc.: Sunshine Biopharma's Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK

(1)
MONTREAL, QC / ACCESSWIRE / December 22, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that its Anti-Coronavirus drug development program is unaffected by the recent discovery of a new strain of Coronavirus in Southern England. The new strain appears to be more easily transmissible due to a mutation in the Spike Protein, the crown-like structure on the surface of the virus which allows it to gain entry into the host cell. Sunshine Biopharma s Anti-Coronavirus compound, SBFM-PL4, acts on the Coronavirus Papain-Like Protease (PLpro) which is a non-structural protein encoded by the viral genome and synthesized by the hijacked protein synthesis machinery of the host cell. Sunshine Biopharma s SBFM-PL4 inhibits PLpro and arrests viral replication. SBFM-PL4 is expected to inhibit the PLpro of the UK variant just as well as it does the original str ....

United Kingdom , Kostenloser Wertpapierhandel , Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , Sunshine Biopharma , Spike Protein , Coronavirus Papain Like Protease , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information , ஒன்றுபட்டது கிஂக்டம் , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , ஸ்பைக் ப்ரோடீந் , எடுப்போசை சுவாச , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் ,

Sunshine Biopharma's Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK

Sunshine Biopharma's Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , Sunshine Biopharma , Spike Protein , Coronavirus Papain Like Protease , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information , ஒன்றுபட்டது கிஂக்டம் , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , ஸ்பைக் ப்ரோடீந் , எடுப்போசை சுவாச , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் , மார்பக புற்றுநோய் ,